NCT03116490 The Effects of Anesthesia Type on the Prognosis of Hip Fracture Surgery on Elderly Patients
| NCT ID | NCT03116490 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wenzhou Medical University |
| Condition | Postoperative Complications |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2026-01-16 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2026-01-16 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to figure out whether anesthesia type have an influence on the prognosis of hip fracture surgery.30-day mortality and morbidity after the surgery are our main observational index,and according to literature and our experience,regional anesthesia may have a better prognosis after hip fracture surgery compared with general anesthesia.
Eligibility Criteria
Inclusion Criteria: * Patients with hip fracture; * Need surgery; * Anesthesia type is regional anesthesia or general anesthesia; * Age≥60 years. Exclusion Criteria: * Choosing conservative treatment; * Other types of anesthesia or without anesthesia.
Contact & Investigator
Ting Li, M.D.
STUDY CHAIR
The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University
Frequently Asked Questions
Who can join the NCT03116490 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Postoperative Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03116490 currently recruiting?
Yes, NCT03116490 is actively recruiting participants. Contact the research team at liting1021@aliyun.com for enrollment information.
Where is the NCT03116490 trial being conducted?
This trial is being conducted at Wenzhou, China.
Who is sponsoring the NCT03116490 clinical trial?
NCT03116490 is sponsored by Wenzhou Medical University. The principal investigator is Ting Li, M.D. at The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University. The trial plans to enroll 600 participants.